Skip to main content

65 millions de dollars US levés en série B pour faire de Heidi le partenaire des professionnels de santé. Lire l’article en anglais

Heidi AI
Se connecterTestez gratuitement

Interrogez les IA à propos de Heidi :

Partager :
Endocrinologist Template

Scribe BC - BG Followup

A professional Endocrinologist template for healthcare professionals.
Use templateBrowse templates

Specialty

Endocrinologist

Used

26 times

Type

Note

Last edited

29/08/2025

Created by

Anonymous

Use template

About this template

Need a clear and concise way to document patient visits for diabetes management? This 'Scribe BC - BG Followup' template is perfect for endocrinologists. It helps streamline the process of recording patient history, medications, examination findings, investigations, and treatment plans. This template ensures all essential details are captured, from blood sugar levels to medication adjustments. With Heidi, the AI scribe, this template can be automatically populated from your patient consultations, saving you time and improving the accuracy of your clinical notes. This template is designed to help you create comprehensive and compliant medical documentation.

Preview template

Scribe BC - BG Followup **REASON FOR VISIT:** The patient presents today for a routine follow-up to manage their type 2 diabetes. **INTERIM HISTORY:** The patient reports stable blood sugars over the past three months, with an average glucose reading of 145 mg/dL. They are using a continuous glucose monitor (CGM) and report no significant hypoglycemic events. The patient denies any new microvascular or macrovascular complications. **PAST MEDICAL HISTORY:** * Type 2 Diabetes Mellitus * Hypertension * Hyperlipidemia **MEDICATIONS:** * Metformin 1000mg twice daily * Lisinopril 20mg daily * Atorvastatin 40mg daily **ALLERGIES:** * NKDA **PHYSICAL EXAMINATION:** * BMI: 32 kg/m² * Blood pressure: 130/80 mmHg * Fundoscopic exam: no signs of diabetic retinopathy * Foot exam: intact sensation, no ulcers **INVESTIGATIONS:** * HbA1c: 7.2% (October 28, 2024) * Lipid panel: within normal limits (October 28, 2024) * Urine microalbumin: negative (October 28, 2024) **IMPRESSION:** * Type 2 Diabetes Mellitus, well-managed * Hypertension, controlled * Hyperlipidemia, controlled **PLAN:** * Continue current medication regimen. * Encourage patient to maintain current diet and exercise routine. * Review CGM data and provide guidance on glucose management. * Discuss potential risks and side effects of medications. * Schedule annual eye exam and foot exam. **FOLLOW-UP:** * Follow-up appointment in three months to review HbA1c and assess overall diabetes management. "This document was created using AI Ambient Scribe and Front-End Speech Recognition software and may include incorrect spelling/words. Consent for usage of AI was obtained by patient/guardian."

How to use this template

1Step 1

Download the template

Get started by downloading the template to your device

2Step 2

Customize to your needs

Tailor the template to match your specific requirements

share template
3Step 3

Deploy and share

Implement your customized template and share with your team

Browse templatesUse template

Exercez en toute sérénité.

Soigner devient plus simple avec Heidi.

Related Templates

Note

Gastroenterology letter

DM

Doctor MEDii

Endocrinologist

5

Note

Endocrinology Consult

HT

Heidi Team

Endocrinologist

36

Note

Endocrine Procedure Note

HT

Heidi Team

Endocrinologist

4

Heidi AI

Chaque jour à vos côtés.

© 2026 Heidi. Tous droits réservés.

imxYAA

Spécialités

  • Médecine générale

  • Médecine spécialisée

  • Paramédical

  • Psychologie et psychiatrie

Conformité

  • Sécurité

  • Centre de confiance

Produit

  • Tarifs

  • Centre d’aide

  • État du système

À propos

  • Nous contacter

  • Témoignages client

  • Rejoindre Heidi

    10+

Ressources

  • Centre de ressources

  • Modèles créés par la communauté

Informations légales

  • Politique de confidentialité

  • Conditions d’utilisation

  • Politique d’utilisation

  • Accessibilité

  • Mentions légales